Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin effects on stress- and fear-related psychobiological functions in healthy men
2021-006814-35Phase 2Active
- Sponsor
- KU Leuven
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial comparing Rifaximin with Placebo (2 arms). Primary endpoints: Salivary cortisol levels, Subjective visual analogue scale stress reports and 2 more. Started Aug 2022; status: active.
02
Drugs
rifaximin
Beyond the preview
Go deeper on 2021-006814-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006814-35.